Sort by
Refine Your Search
-
OSU | about 1 month ago
-Comprehensive Cancer Center Department: CCC | Sponsored Research Scope/Summary: The Researcher 1 will support the Center for Antibody Therapeutics (CAT) within the Pelotonia Institute for Immuno-Oncology (PIIO
-
OSU | about 2 months ago
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected] . If you have questions while submitting an application
-
OSU | about 2 months ago
methodology. It has supported numerous federally funded research studies spanning topic areas that cover both basic and translational science. The postd doctoral scholar will work closely with their
-
OSU | about 2 months ago
methodology. It has supported numerous federally funded research studies spanning topic areas that cover both basic and translational science. The postd doctoral scholar will work closely with their
-
OSU | about 2 months ago
methodology. It has supported numerous federally funded research studies spanning topic areas that cover both basic and translational science. The postd doctoral scholar will work closely with their
-
OSU | about 2 months ago
foundational (basic) biological/health science research laboratory investigating lung aging, regeneration, and fibrosis in the Department of Internal Medicine, Division Pulmonary, Critical Care
-
OSU | about 1 month ago
Pelotonia Institute for Immuno-Oncology (PIIO), is devoted to unraveling the complex interactions between immune cells and tumor cells, with a particular focus on elucidating the functional dynamics of
-
more years) in a social science discipline and in conducting research. Six or more years of experience with programmed survey conversion and testing. Expertise in SAS or equivalent programming
-
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected] . If you have questions while submitting an application
-
OSU | about 1 month ago
Institute for Immuno-Oncology (PIIO). The laboratory of Dr. Acharya studies how cellular and molecular determinants in the neuro-immune axis influence cancer initiation, progression, and metastasis